Minister Husic inaugurates Device Technologies’ new distribution centre, paving the way for local manufacturing expansion

MedTech company, Device Technologies, has unveiled its cutting-edge National Distribution Centre, with the presence of Ed Husic MP, Minister for Industry and Science. Nestled within Sydney’s Marsden Park, the premises will serve as a lynchpin for the distribution of both locally manufactured and imported medical technologies to healthcare providers across Australia and New Zealand.

Minister Husic, in his address, underscored the pivotal role of fortifying local employment and propelling the country’s healthcare capabilities forward. He emphasised the imperative of amplifying domestic manufacturing, citing the centre’s contribution as instrumental in realising this overarching national objective.

Developed by Sydney Business Park and custom built by Prime Constructions, the facility has a five-star Green Star rating.

Echoing Minister Husic’s sentiments, Mick Trevaskis, CEO of Device Technologies, outlined the company’s strategy aimed at enriching Australia’s healthcare landscape through strategic diversification of the supply chain.

“Since my appointment, we’ve significantly diversified our supply chain. From a position where 98% of our products were imported, we’ve now expanded our domestic production to account for 22% of our offerings through onshore manufacturing and OEM,” he stated.

The House Standing Committee on Industry, Science and Resources tabled its inquiry report Sovereign, smart, sustainable: Driving advanced manufacturing in Australia at the end of November last year.

The Chair of the Committee, Rob Mitchell MP, said “Manufacturing has been in decline in this country since the sixties. Now is the time to turn that around and set Australia on a course to becoming globally competitive in advanced manufacturing.”

He added “The notion that Australian-made products cannot compete with foreign alternatives is now outdated. With advanced manufacturing processes and techniques, particularly Industry 4.0 technologies, Australian manufacturing can be globally competitive – including on cost.”

Mr Trevaskis further articulated the company’s aspiration to escalate local production to 50% within the ensuing five years, acknowledging the indispensable role of governmental support in mitigating the costs associated with local manufacturing.

Device Technologies is actively pursuing this objective by acquiring struggling local manufacturing entities.

“Our strategy is not just about expansion; it’s about nurturing the local expertise to develop new, market-specific products,” explained Mr Trevaskis, underscoring the company’s dedication to reshaping healthcare delivery and manufacturing paradigms within the region.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.